Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02951156
Title Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Pfizer
Indications

diffuse large B-cell lymphoma

Therapies

Avelumab + Azacitidine + Utomilumab

Avelumab + Rituximab + Utomilumab

Bendamustine + Rituximab

Gemcitabine + Oxaliplatin + Rituximab

Avelumab + Bendamustine + Rituximab

Age Groups: senior | adult
Covered Countries USA | ITA | ESP | BEL

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Norton Cancer Institute Louisville Kentucky 40207 United States Details
Norton Diagnostic Center - Dupont Louisville Kentucky 40207 United States Details
Norton Women's and Children's Hospital Louisville Kentucky 40207 United States Details
Tulane Medical Center New Orleans Louisiana 70112 United States Details
Parexel International Billerica Massachusetts 01821 United States Details
University of Michigan Health System Ann Arbor Michigan 48109 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
North Shore Hematology Oncology Associates East Setauket New York 11733 United States Details
St. George Hospital Kogarah New South Wales 2217 Australia Details
Monash Health Clayton Victoria 3168 Australia Details
Cancer Clinical Trials Centre, Austin Health, Level 4 Heidelberg Victoria 3084 Australia Details
Genesis Care Heidelberg Victoria 3084 Australia Details
UZ Gent Gent 9000 Belgium Details
UZ Leuven Leuven 3000 Belgium Details
Farmacia Studi Clinici Rozzano MI 20089 Italy Details
Istituto Clinico Humanitas Rozzano MI 20089 Italy Details
Samsung Medical Center Clinical Trial Pharmacy Seoul 06351 Korea, Republic of Details
Samsung Medical Center Seoul 06351 Korea, Republic of Details
Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli Lublin Lubelskie 20-090 Poland Details
Malopolskie Centrum Medyczne S.C. Krakow Malopolskie 30-510 Poland Details
Nzoz McD Voxel Osrodek Pet-Tk-Nmr Krakow 30-006 Poland Details
Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli Oddzial Hematologiczny Lublin 20-090 Poland Details
NU-MED Centrum Diagnostyki i Terapii Onkologicznej Zamosc Sp. z o.o. Zamosc 22-400 Poland Details
Hospital San Pedro de Alcantara Caceres 10003 Spain Details
Hospital San Pedro de Alcantara Cáceres 10003 Spain Details
Centro de Investigación Medicina Especializada Sanitaria (CIMES) Málaga 29010 Spain Details
Hospital Universitario Virgen de la Victoria Málaga 29010 Spain Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
The Christie Pathology Partnership Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field